Genetic profiling of hepatocellular carcinoma using next-generation sequencing

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) is a complex liver cancer with significant clinical and molecular diversity.
• Next-generation sequencing (NGS) technologies enable detailed analysis of molecular alterations in HCC.
• Understanding these alterations is crucial for developing targeted therapies.

Purpose of the Study:

• To review the current knowledge of deep sequencing applications in HCC.
• To explore the identification and significance of molecular signatures in HCC.
• To discuss the potential clinical impact of these findings on HCC treatment.

Main Methods:

• Analysis of deep sequencing data from HCC samples.
• Identification of cancer driver genes and oncogenic pathways.
• Characterization of mutational signatures linked to external factors.
• Consideration of intra- and inter-tumor heterogeneity.

Main Results:

• Deep sequencing has uncovered key driver genes and pathways in HCC.
• Specific nucleotide patterns, or mutational signatures, have been identified in HCC.
• Molecular signatures offer insights into tumor heterogeneity.
• Functional validation of these signatures is essential.

Conclusions:

• Deep sequencing provides valuable insights into HCC molecular landscape.
• Mutational signatures can potentially predict treatment response to molecular therapies.
• Further research into molecular signatures holds promise for personalized HCC treatment.